-
- Posted Monday May 5, 2014
TGen Dr. Bodour Salhia named to 2014 Class of 40 Under 40
Newspaper recognizes TGen cancer researcher among Phoenix's brightest young leaders
PHOENIX, Ariz. - May 5, 2014 - Dr. Bodour
Salhia, a cancer researcher at the Translational Genomics Research
Institute (TGen), has been named one of the Phoenix
Business Journal's 2014 Class of 40 Under 40.
Dr. Salhia, an Assistant Professor in TGen's Integrated Cancer
Genomics Division, will be among the 40 up-and-coming Phoenix
leaders - less than 40 years of age - at an awards reception June
19 at Phoenix Theater.
In his award notification letter to Dr. Salhia, PBJ
Publisher Don Henninger said, "I speak for all the judges in saying
that we feel honored to have seen a glimpse of your life and
career. You are most certainly a valuable member of our community
and a source of inspiration for all."
All 40 Under 40 classmates will be featured in a special
section of the June 20 edition of the PBJ.
"Bodour is a gem; brilliant and transparent. She is an incredible
asset to TGen and to the state of Arizona. Watching her growth and
career ascent has been one of the highlights of my entire career,"
said Dr. John Carpten, TGen Deputy Director of Basic Science.
"She is an amazing scientist, but also frequently participates in
patient advocacy and community education," said Dr. Carpten, also
Professor and Director of TGen's Integrated Cancer Genomics
Division. "We are so proud of Bodour. To me, this is not simply a
recognition of her achievements, but also a reward for all that she
does for others."
Dr. Salhia, who specializes in researching breast cancer and
multiple myeloma, is the fourth TGen staff member in three years to
be selected to PBJ's 40 Under 40. Dr. Matt
Huentelman, an Associate Professor in TGen's Neurogenomics
Division, and Dr. Glen Weiss, a Clinical Associate Professor in
TGen's Cancer and Cell Biology Division, were named in 2013. Dr.
Candice Nulsen, TGen's former Director of Education and Community
Outreach, was selected in 2012.
"I am so thankful and humbled to be selected among this year's
40 Under 40 by the Phoenix Business Journal,"
said Dr. Salhia, whose community work has included outreach to
cancer patients of the Navajo Nation, and service as a board member
of Susan G. Komen for the Cure, Central and Northern Arizona
Affiliate. "This award is not just about me, but also reflects all
the cutting-edge research that TGen conducts, using the human
genome to devise better treatments for patients
today."
The 40 Under 40 program's hundreds of alumni includes
Phoenix Mayor Greg Stanton, a member of the TGen Board of
Directors, and Arizona Diamondbacks President Derrick Hall, a
member of TGen's National Advisory Council for Pancreatic Cancer
Research.
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
